Localization of Mullerian inhibiting substance receptors in various human cancer cell lines

被引:0
|
作者
A. V. Rodina
N. V. Gukasova
V. A. Makarov
I. G. Kondrasheva
A. V. Khomyakova
G. A. Posypanova
O. N. Popova
E. Yu. Moskaleva
S. E. Severin
机构
[1] Moscow Research Institute of Medical Ecology,Moscow Department of Health Care
来源
Biochemistry (Moscow) | 2008年 / 73卷
关键词
human recombinant MIS; receptor localization; biological activity;
D O I
暂无
中图分类号
学科分类号
摘要
Recombinant human MIS (rhMIS) produced in transfected Chinese hamster ovary cells has been purified by immunoaffinity chromatography. In the absence of reducing agents, 140 kD homodimer and several oligomers with molecular masses from 280 to 1000 kD are present. Homodimer, tetramer, and higher-molecular-weight rhMIS fractions reduced survival of tumor cells. For these experiments, FITC-labeled rhMIS was used for binding and endocytosis studies by flow cytometry. Flow cytometry performed on MIS-sensitive cancer cell lines demonstrated specific binding of rhMIS. The majority of rhMIS receptors have cytosolic localization. Thus, the level of MIS receptors on the cell membrane was pro-portional to the content of MIS-binding proteins in the whole cell and defines a level of receptor-mediated endocytosis. The immunopurified rhMIS caused significant growth inhibition of ovarian and prostate adenocarcinoma and melanoma human cell lines in inhibition assays.
引用
收藏
相关论文
共 50 条
  • [31] Expression of Mullerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer
    Song, Jae Yen
    Jo, Hyun Hee
    Kim, Mee Ran
    Lew, Young Oak
    Ryu, Ki Sung
    Cha, Jung Ho
    Kang, Chang Suk
    Donahoe, Patricia K.
    MacLaughlin, David T.
    Kim, Jang Heub
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 2013 - 2021
  • [32] Identification of large-scale characteristic genes of Mullerian inhibiting substance in human ovarian cancer cells
    Nam, Suk Woo
    Jo, Yun Sung
    Eun, Jung Woo
    Song, Jae Yen
    Ryu, Ki Sung
    Lee, Jung Young
    Lee, Joon Mo
    MacLaughlin, David T.
    Kim, Jang Heub
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (05) : 589 - 596
  • [33] CELLULAR-LOCALIZATION OF MULLERIAN INHIBITING SUBSTANCE MESSENGER-RIBONUCLEIC-ACID DURING HUMAN OVARIAN FOLLICULAR DEVELOPMENT
    WHITMAN, GF
    PANTAZIS, CG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (06) : 1881 - 1886
  • [34] Cholecystokinin receptors in human pancreatic cancer cell lines
    Mandair, KK
    Towner, P
    Stamford, IF
    Morris, JD
    Harper, E
    Benjamin, IS
    Tavares, IA
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (09) : 1455 - 1459
  • [35] HUMAN MULLERIAN INHIBITING SUBSTANCE INHIBITS TUMOR-GROWTH INVITRO AND INVIVO
    CHIN, TW
    PARRY, RL
    DONAHOE, PK
    CANCER RESEARCH, 1991, 51 (08) : 2101 - 2106
  • [36] TOXICITY OF MULLERIAN INHIBITING SUBSTANCE TO CELLS DERIVED FROM A HUMAN ENDOMETRIAL TUMOR
    PRICE, JM
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1982, 18 (03): : 323 - 323
  • [37] Mullerian Inhibiting Substance Induces Apoptosis of Human Endometrial Stromal Cells in Endometriosis
    Namkung, Jeong
    Song, Jae Yen
    Jo, Hyun Hee
    Kim, Mee Ran
    Lew, Young Oak
    Donahoe, Patricia K.
    MacLaughlin, David T.
    Kim, Jang Heub
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : 3224 - 3230
  • [38] Localization of WT-1, inhibin, mullerian inhibiting substance and p53 in gonadoblastomas
    Hussong, J
    Crussi, FG
    Chou, PM
    LABORATORY INVESTIGATION, 1997, 76 (01) : 15 - 15
  • [39] MULLERIAN INHIBITING SUBSTANCE INHIBITION OF A HUMAN ENDOMETRIAL CARCINOMA CELL-LINE XENOGRAFTED IN NUDE-MICE
    FULLER, AF
    BUDZIK, GP
    KRANE, IM
    DONAHOE, PK
    GYNECOLOGIC ONCOLOGY, 1984, 17 (01) : 124 - 132
  • [40] Identification of characteristic molecular signature of Mullerian inhibiting substance in human HPV-related cervical cancer cells
    Hwang, Seong Jin
    Suh, Min Jung
    Yoon, Joo Hee
    Kim, Mee Ran
    Ryu, Ki Sung
    Nam, Suk Woo
    Donahoe, Patricia K.
    MacLaughlin, David T.
    Kim, Jang Heub
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (04) : 811 - 820